Immatics N.V.

NASDAQ:IMTX

Biotechnology

Healthcare
$5.95 +1.58%

+$0.15 today

Market cap
$890.33M
Beta
1.30
P/E (TTM)
-5.3
EPS (TTM)
-$1.59
52W Low $5.05High $12.41

Volume 0.99M

Average 0.46M

Returns on capital

Immatics N.V. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-40.6%

avg -37.6%

ROIC

-34.3%

avg -43.6%

ROA

-34.9%

avg -32.7%

Analysis

ROIC is currently the strongest return metric at -34.3% versus its period average of -43.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Harpreet Singh

Chief Executive Officer, MD, Member of Management Board & Executive DirectorEUR 970.64K51——

James Pepin

General Counsel & Corporate Secretary————

Carsten Reinhardt

Chief Development Officer—59——

Hans-Georg Rammensee

Co-Founder & Member of the Scientific Advisory Board————

Toni Weinschenk

Co-Founder & Chief Innovation Officer—56——

Venkat Ramanan

Chief Financial Officer—56350.00K0.26%

Ephraim Hofsäß

Vice President of SEC Reporting & Accounting————

Steffen Walter

Chief Operations Officer—49——

Amie Krause

Chief People Officer—53——

Lauren Schroeder

Vice President of Marketing————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 18, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

1

$7.50M

Sells

0

$0.00

Net Transaction Value

+$7.50M

Net buying

Most Active

PERCEPTIVE ADVISORS LLC

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 26, 26

PERCEPTIVE ADVISORS LLC

Indirect

Buy$7.5M

Summary

Insiders reported 1 buys worth $7.50M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $7.50M. PERCEPTIVE ADVISORS LLC was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/A-34.6%
+55.7% (5yr)6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Recent growth has been strongest in Revenue at -34.6% over three years. Forward estimates point to Revenue at +55.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Immatics N.V. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about IMTX's management, answered from reported figures.

Who manages IMTX?

Immatics N.V. (IMTX) lists 10 active executives. The top listed executive is James Pepin, General Counsel & Corporate Secretary.

Are IMTX insiders buying or selling?

Recent insider activity shows net buying of $13.14M.